These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36048542)

  • 1. Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival.
    Vijayakurup V; Maeng K; Lee HS; Meyer B; Burkett S; Nawab A; Dougherty MW; Jobin C; Mahmud I; Garrett TJ; Feely M; Lee KB; Kaye FJ; Guijarro MV; Zajac-Kaye M
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36048542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization.
    Capodanno Y; Chen Y; Schrader J; Tomosugi M; Sumi S; Yokoyama A; Hiraoka N; Ohki R
    Neoplasia; 2021 Sep; 23(9):979-992. PubMed ID: 34352404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two well-differentiated pancreatic neuroendocrine tumor mouse models.
    Wong C; Tang LH; Davidson C; Vosburgh E; Chen W; Foran DJ; Notterman DA; Levine AJ; Xu EY
    Cell Death Differ; 2020 Jan; 27(1):269-283. PubMed ID: 31160716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.
    Lin W; Francis JM; Li H; Gao X; Pedamallu CS; Ernst P; Meyerson M
    Cancer Biol Ther; 2016 Dec; 17(12):1274-1281. PubMed ID: 27801610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.
    Chen M; Rahman L; Voeller D; Kastanos E; Yang SX; Feigenbaum L; Allegra C; Kaye FJ; Steeg P; Zajac-Kaye M
    Oncogene; 2007 Jul; 26(33):4817-24. PubMed ID: 17297449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression.
    Xu J; Ye Z; Zhuo Q; Gao H; Qin Y; Lou X; Zhang W; Wang F; Wang Y; Jing D; Fan G; Zhang Y; Chen X; Chen J; Xu X; Yu X; Ji S
    Cancer Res; 2023 Jul; 83(13):2226-2247. PubMed ID: 36939378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergence between germline and somatic mutations in pancreatic neuroendocrine tumors.
    Ling C; Hong X; Xu M; Wang Y; Ma X; Cui Y; Jiang R; Cao D; Wu H; Tong A; Zhao Y; Wu W
    Eur J Endocrinol; 2022 May; 187(1):85-90. PubMed ID: 35521758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors.
    Ohki R; Saito K; Chen Y; Kawase T; Hiraoka N; Saigawa R; Minegishi M; Aita Y; Yanai G; Shimizu H; Yachida S; Sakata N; Doi R; Kosuge T; Shimada K; Tycko B; Tsukada T; Kanai Y; Sumi S; Namiki H; Taya Y; Shibata T; Nakagama H
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2404-13. PubMed ID: 24912192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors.
    Lakiza O; Lutze J; Vogle A; Williams J; Abukdheir A; Miller P; Liao C'; Pitroda SP; Martinez C; Olivas A; Setia N; Kron SJ; Weichselbaum RR; Keutgen XM
    Endocr Relat Cancer; 2022 Mar; 29(4):225-239. PubMed ID: 35171113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
    Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
    Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progranulin Stimulates Proliferation of Mouse Pancreatic Islet Cells and Is Overexpressed in the Endocrine Pancreatic Tissue of an MEN1 Mouse Model.
    Barbu A; Lejonklou MH; Skogseid B
    Pancreas; 2016 Apr; 45(4):533-40. PubMed ID: 26495792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
    Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
    Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
    Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
    Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.
    Fuentes ME; Lu X; Flores NM; Hausmann S; Mazur PK
    Sci Rep; 2024 Apr; 14(1):8510. PubMed ID: 38609433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
    Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
    Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line.
    Monazzam A; Li SC; Wargelius H; Razmara M; Bajic D; Mi J; Bergquist J; Crona J; Skogseid B
    Sci Rep; 2020 Sep; 10(1):14572. PubMed ID: 32884006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.
    Park JK; Paik WH; Lee K; Ryu JK; Lee SH; Kim YT
    Oncotarget; 2017 Jul; 8(30):49796-49806. PubMed ID: 28591701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup.
    Chan CS; Laddha SV; Lewis PW; Koletsky MS; Robzyk K; Da Silva E; Torres PJ; Untch BR; Li J; Bose P; Chan TA; Klimstra DS; Allis CD; Tang LH
    Nat Commun; 2018 Oct; 9(1):4158. PubMed ID: 30315258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p27
    Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
    J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis.
    Hackeng WM; Brosens LA; Poruk KE; Noë M; Hosoda W; Poling JS; Rizzo A; Campbell-Thompson M; Atkinson MA; Konukiewitz B; Klöppel G; Heaphy CM; Meeker AK; Wood LD
    Hum Pathol; 2016 Oct; 56():93-100. PubMed ID: 27342911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.